Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide)

Cat.No ACMA00003219

Basic Information Description Application Features And Benefits

Catalog Number	ACMA00003219
Synonyms	PEG-PLGA, mPEG-b-PLGA
Molecular Weight	PEG average Mn 5,000 PLGA Mn 5,000
Molecular Formula	H[(C3H4O2)x(C2H2O2)y]mO[C2H4O]nCH3
Quality Level	100
Storage Temperature	−20°C

Description Contains ≤500 ppm impurities by GC, including trace monomer and residual organics.

Application Biocompatible block copolymer. Can be used in the formation of nanoparticles for drug delivery. Potential use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents.

Features And Benefits Good biocompatibility;
Properties can be easily modulated by changing the block copolymer segment sizes to suit a particular application.

Our products and services are for research use only and cannot be used for any clinical purpose.

The Following May Also Be of Interest to You

• 

  Polylactide-block-poly(ethylene glycol)-block-polylactide

  Cat.No. ACMA00003232

• 

  Poly(ethylene glycol) methyl ether-block-poly(L-lactide-co-glycolide)

  Cat.No. ACMA00014050

• 

  Allyl poly(ethylene glycol)-block-poly(lactide-co-glycolide)

  Cat.No. ACMA00040484

• 

  Amine poly(ethylene glycol)-block-poly(lactide-co-glycolide)

  Cat.No. ACMA00040485

• 

  Carboxylic acid poly(ethylene glycol)-block-poly(lactide-co-glycolide)

  Cat.No. ACMA00040486

• 

  Carboxylic acid-poly(ethylene glycol)-b-poly(lactide-co-glycolide)

  Cat.No. ACMA00040487